Amgen Inc (AMGN)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Receivables turnover		3.27	3.00	3.17	3.20	2.92	9.59	9.60	10.13	8.80	5.35	5.69	5.69	4.78	6.10	4.53	4.78	5.02	6.49	6.20	6.30
DSO	days	111.60	121.73	115.26	113.90	125.10	38.04	38.02	36.05	41.49	68.28	64.15	64.15	76.43	59.80	80.60	76.29	72.68	56.26	58.88	57.95

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.27
= 111.60

To analyze AMGEN Inc.'s Days Sales Outstanding (DSO) performance, we observe a trend of fluctuating DSO values over the past eight quarters. The company's DSO ranged from a low of 70.42 days in Q2 2022 to a high of 96.33 days in Q4 2023.

Overall, there has been a gradual increase in DSO from Q2 2022 to Q4 2023, indicating that the company may be taking longer to collect its accounts receivable. This trend suggests that AMGEN Inc. may be facing challenges in efficiently managing its receivables, potentially impacting its liquidity and cash flow.

It is essential for the company to closely monitor its DSO metrics and implement strategies to improve collections and shorten the time it takes to convert sales into cash. By reducing DSO, AMGEN Inc. can enhance its working capital position, strengthen financial health, and optimize operational efficiency.